Inhaled Beta-2-Agonists/Muscarinic Antagonists and Acute Myocardial Infarction in COPD Patients

Respiratory Medicine - United Kingdom
doi 10.1016/j.rmed.2014.05.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inhaled Short Acting Beta Agonist Use in COPD and the Risk of Acute Myocardial Infarction

Thorax
PulmonaryRespiratory Medicine
2003English

Developing LRP1 Agonists Into a Therapeutic Strategy in Acute Myocardial Infarction

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Beta-Blocker Initiation and Adherence After Hospitalization for Acute Myocardial Infarction

European Journal of Cardiovascular Prevention & Rehabilitation
2011English

Factors Predicting Beta-Blocker Treatment After Myocardial Infarction in Patients With Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Symptom Expectations and Delay in Acute Myocardial Infarction Patients

Heart
2001English

Propranolol for Infants With Hemangioma: Confusion Between Beta Agonists and Beta Antagonists

Angiology: Open Access
2016English

Acute Myocardial Infarction

British Medical Journal
Medicine
2014English

Acute Myocardial Infarction

The Professional Medical Journal
2018English

Atrial Fibrillation in Patients Hospitalized With Acute Myocardial Infarction: Analysis of the China Acute Myocardial Infarction (CAMI) Registry

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy